Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandrine Poglio

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
The Journal of Investigative Dermatology|July 24, 2018
SATB1 Is a Pivotal Epigenetic Biomarker in Cutaneous T-Cell LymphomasSandrine Poglio, Jean-Philippe Merlio
Stem Cells (Dayton, Ohio)|September 17, 2010
Adipose tissue as a dedicated reservoir of functional mast cell progenitorsSandrine Poglio, Fabienne De Toni-Costes, Emmanuelle Arnaud, et al.
The American Journal of Pathology|December 20, 2008
Adipose tissue sensitivity to radiation exposureSandrine Poglio, Sylvain Galvani, Sandy Bour, et al.
Stem Cells and Development|March 11, 2011
Human adipose-derived stromal cells efficiently support hematopoiesis in vitro and in vivo: a key step for therapeutic studiesFabienne De Toni, Sandrine Poglio, Aissa Ben Youcef, et al.
Blood|October 17, 2012
In situ production of innate immune cells in murine white adipose tissueSandrine Poglio, Fabienne De Toni, Daniel Lewandowski, et al.
Leukemia|October 27, 2020
Xenograft and cell culture models of Sézary syndrome reveal cell of origin diversity and subclonal heterogeneitySandrine Poglio, Martina Prochazkova-Carlotti, Floriane Cherrier, et al.
Cancers|October 31, 2018
Calcium Independent Effect of Orai1 and STIM1 in Non-Hodgkin B Cell Lymphoma DisseminationSimon Latour, Isabelle Mahouche, Floriane Cherrier, et al.
The American Journal of Pathology|May 17, 2016
Intrahepatic Xenograft of Cutaneous T-Cell Lymphoma Cell Lines: A Useful Model for Rapid Biological and Therapeutic EvaluationLaetitia Andrique, Sandrine Poglio, Martina Prochazkova-Carlotti, et al.
Frontiers in Oncology|November 12, 2021
Targeting Epigenetic Modifiers Can Reduce the Clonogenic Capacities of Sézary CellsAlain Chebly, Martina Prochazkova-Carlotti, Yamina Idrissi, et al.
Oncotarget|May 19, 2016
Speed of leukemia development and genetic diversity in xenograft models of T cell acute lymphoblastic leukemiaSandrine Poglio, Daniel Lewandowski, Julien Calvo, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
The Journal of Investigative Dermatology|July 24, 2018
SATB1 Is a Pivotal Epigenetic Biomarker in Cutaneous T-Cell LymphomasSandrine Poglio, Jean-Philippe Merlio
Stem Cells (Dayton, Ohio)|September 17, 2010
Adipose tissue as a dedicated reservoir of functional mast cell progenitorsSandrine Poglio, Fabienne De Toni-Costes, Emmanuelle Arnaud, et al.
The American Journal of Pathology|December 20, 2008
Adipose tissue sensitivity to radiation exposureSandrine Poglio, Sylvain Galvani, Sandy Bour, et al.
Stem Cells and Development|March 11, 2011
Human adipose-derived stromal cells efficiently support hematopoiesis in vitro and in vivo: a key step for therapeutic studiesFabienne De Toni, Sandrine Poglio, Aissa Ben Youcef, et al.
Blood|October 17, 2012
In situ production of innate immune cells in murine white adipose tissueSandrine Poglio, Fabienne De Toni, Daniel Lewandowski, et al.
Leukemia|October 27, 2020
Xenograft and cell culture models of Sézary syndrome reveal cell of origin diversity and subclonal heterogeneitySandrine Poglio, Martina Prochazkova-Carlotti, Floriane Cherrier, et al.
Cancers|October 31, 2018
Calcium Independent Effect of Orai1 and STIM1 in Non-Hodgkin B Cell Lymphoma DisseminationSimon Latour, Isabelle Mahouche, Floriane Cherrier, et al.
The American Journal of Pathology|May 17, 2016
Intrahepatic Xenograft of Cutaneous T-Cell Lymphoma Cell Lines: A Useful Model for Rapid Biological and Therapeutic EvaluationLaetitia Andrique, Sandrine Poglio, Martina Prochazkova-Carlotti, et al.
Frontiers in Oncology|November 12, 2021
Targeting Epigenetic Modifiers Can Reduce the Clonogenic Capacities of Sézary CellsAlain Chebly, Martina Prochazkova-Carlotti, Yamina Idrissi, et al.
Oncotarget|May 19, 2016
Speed of leukemia development and genetic diversity in xenograft models of T cell acute lymphoblastic leukemiaSandrine Poglio, Daniel Lewandowski, Julien Calvo, et al.
Pageof 3